{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:25:23Z","timestamp":1786292723289,"version":"build-2736575974"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["552276\/2011-1"],"award-info":[{"award-number":["552276\/2011-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227876","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T13:45:21Z","timestamp":1579009521000},"page":"e0227876","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Promising antifungal activity of new oxadiazole against Candida krusei"],"prefix":"10.1371","volume":"15","author":[{"given":"Daniella Renata","family":"Faria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Mayumi","family":"Sakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis Regina Grenier","family":"Capoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaucia Sayuri","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciele Abigail Vilugron","family":"Rodrigues-Vendramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Admilton Gon\u00e7alves","family":"de Oliveira Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sueli","family":"Soares Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia de Souza","family":"Bonfim de Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha Inez Estivalet","family":"Svidzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-8577","authenticated-orcid":true,"given":"Erika Seki","family":"Kioshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"issue":"9","key":"pone.0227876.ref001","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational Surveillance of Fungemia in Denmark: Notably High Rates of Fungemia and Numbers of Isolates with Reduced Azole Susceptibility","volume":"43","author":"MC Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"pone.0227876.ref002","first-page":"14","article-title":"Emerging fungal infections in immunocompromised patients","volume":"3","author":"C-Y Low","year":"2011","journal-title":"F1000 Med Rep"},{"key":"pone.0227876.ref003","volume-title":"Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals","author":"European Centre for Disease Prevention and Control","year":"2019"},{"issue":"1","key":"pone.0227876.ref004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.riam.2016.02.006","article-title":"Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013","volume":"34","author":"G Motoa","year":"2017","journal-title":"Rev Iberoam Micol"},{"key":"pone.0227876.ref005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The Changing Epidemiology of Invasive Fungal Infections","volume":"1508","author":"DA Enoch","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"10","key":"pone.0227876.ref006","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","article-title":"Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period","volume":"40","author":"AL Colombo","year":"2014","journal-title":"Intensive Care Med"},{"key":"pone.0227876.ref007","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","article-title":"Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study","volume":"6","author":"O Leroy","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"1","key":"pone.0227876.ref008","doi-asserted-by":"crossref","first-page":"e0146909","DOI":"10.1371\/journal.pone.0146909","article-title":"Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program","volume":"11","author":"AM Doi","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"pone.0227876.ref009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid2301.161198","article-title":"Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002\u20132012","volume":"23","author":"S Strollo","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"pone.0227876.ref010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"6","author":"J Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"pone.0227876.ref011","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S1517-838246120120296","article-title":"Clinical significance of the isolation of Candida species from hospitalized patients","volume":"46","author":"YC Magalh\u00e3es","year":"2015","journal-title":"Braz J Microbiol"},{"issue":"1","key":"pone.0227876.ref012","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0974-777X.199995","article-title":"Studying the Prevalence, Species Distribution, and Detection of In vitro Production of Phospholipase from Candida Isolated from Cases of Invasive Candidiasis","volume":"9","author":"Y Sharma","year":"2017","journal-title":"J Glob Infect Dis"},{"issue":"3","key":"pone.0227876.ref013","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/S0074-02762013000300005","article-title":"Historical trends in the epidemiology of candidemia: analysis of an 11-year period in a tertiary care hospital in Brazil","volume":"108","author":"MP Wille","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"10","key":"pone.0227876.ref014","doi-asserted-by":"crossref","first-page":"e0165346","DOI":"10.1371\/journal.pone.0165346","article-title":"Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia","volume":"11","author":"M Ishikane","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"pone.0227876.ref015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkh532","article-title":"Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital","volume":"55","author":"P Mu\u00f1oz","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"pone.0227876.ref016","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"MA Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"6","key":"pone.0227876.ref017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12223-017-0525-8","article-title":"Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients","volume":"62","author":"V Hrabovsk\u00fd","year":"2017","journal-title":"Folia Microbiol (Praha)"},{"issue":"18","key":"pone.0227876.ref018","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"JR Wingard","year":"1991","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0227876.ref019","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1128\/AAC.01005-15","article-title":"Rapid development of Candida krusei echinocandin resistance during caspofungin therapy","volume":"59","author":"A Forastiero","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0227876.ref020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/bmt.2014.230","article-title":"Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit","volume":"50","author":"E Tavernier","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"pone.0227876.ref021","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"PG Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pone.0227876.ref022","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for Treatment of Candidiasis","volume":"38","author":"PG Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0227876.ref023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"R Laniado-Labor\u00edn","year":"2009","journal-title":"Rev Iberoam Micol"},{"issue":"5","key":"pone.0227876.ref024","doi-asserted-by":"crossref","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","article-title":"Antifungal drug development: challenges, unmet clinical needs, and new approaches","volume":"4","author":"T Roemer","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"20","key":"pone.0227876.ref025","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"ES Arn\u00e9r","year":"2000","journal-title":"Eur J Biochem."},{"issue":"11","key":"pone.0227876.ref026","doi-asserted-by":"crossref","first-page":"e0142926","DOI":"10.1371\/journal.pone.0142926","article-title":"Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus","volume":"10","author":"AKR Abadio","year":"2015","journal-title":"PLoS One"},{"key":"pone.0227876.ref027","article-title":"Composi\u00e7\u00e3o farmac\u00eautica baseada em compostos 1,3,4-oxadiaz\u00f3licos e seu uso na prepara\u00e7\u00e3o de medicamentos para tratamento de infec\u00e7\u00f5es sist\u00eamicas","author":"ES Kioshima","year":"2018","journal-title":"BR 10 2018 009020 8"},{"issue":"6","key":"pone.0227876.ref028","doi-asserted-by":"crossref","first-page":"e0007441","DOI":"10.1371\/journal.pntd.0007441","article-title":"Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment","volume":"13","author":"FAV Rodrigues-Vendramini","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0227876.ref029","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fmicb.2019.02130","article-title":"Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans","volume":"10","author":"IRG Capoci","year":"2019","journal-title":"Front Microbiol"},{"key":"pone.0227876.ref030","volume-title":"CLSI document M27-A3","author":"CLSI","year":"2008"},{"key":"pone.0227876.ref031","volume-title":"Fourth Informational Supplement. CLSI document M27-S4","author":"CLSI","year":"2012"},{"issue":"6","key":"pone.0227876.ref032","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/AAC.41.6.1392","article-title":"Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans","volume":"41","author":"ME Klepser","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pone.0227876.ref033","first-page":"1068","article-title":"Comparison of methods used for assessing the viability and vitality of yeast cells","volume":"14","author":"M Kwolek-Mirek","year":"2014","journal-title":"FEMS Yeast Res"},{"key":"pone.0227876.ref034","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fmicb.2016.00113","article-title":"Bioactive Organocopper Compound from Pseudomonas aeruginosa Inhibits the Growth of Xanthomonas citri subsp. citri","volume":"7","author":"AG De Oliveira","year":"2016","journal-title":"Front Microbiol"},{"key":"pone.0227876.ref035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2017.00535","article-title":"Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans","volume":"8","author":"LS Joffe","year":"2017","journal-title":"Front Microbiol"},{"issue":"1","key":"pone.0227876.ref036","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/13693786.2011.582890","article-title":"Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans","volume":"50","author":"MS Khan","year":"2011","journal-title":"Med Mycol"},{"issue":"3","key":"pone.0227876.ref037","first-page":"e00647","article-title":"Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids","volume":"6","author":"V Mor","year":"2015","journal-title":"MBio"},{"issue":"2","key":"pone.0227876.ref038","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1574-6968.2010.02170.x","article-title":"Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model","volume":"315","author":"A Khodavandi","year":"2011","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"pone.0227876.ref039","doi-asserted-by":"crossref","first-page":"e85836","DOI":"10.1371\/journal.pone.0085836","article-title":"In vitro and in vivo activity of a novel antifungal small molecule against Candida infections","volume":"9","author":"SS Wong","year":"2014","journal-title":"PLoS One"},{"key":"pone.0227876.ref040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"JA DiMasi","year":"2016","journal-title":"J Health Econ"},{"key":"pone.0227876.ref041","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymeth.2014.10.019","article-title":"Structure based virtual screening to discover putative drug candidates: necessary considerations and successful case studies","volume":"71","author":"M Danishuddin","year":"2015","journal-title":"Methods"},{"issue":"8","key":"pone.0227876.ref042","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1517\/17460441.2010.498472","article-title":"Discovery and characterization of \u00df-1,6-glucan inhibitors","volume":"5","author":"A Kitamura","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"pone.0227876.ref043","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/npjbiofilms.2015.12","article-title":"A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance","volume":"1","author":"CG Pierce","year":"2015","journal-title":"NPJ Biofilms Microbiomes"},{"key":"pone.0227876.ref044","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3389\/fmicb.2015.01453","article-title":"Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms","volume":"6","author":"T Watamoto","year":"2015","journal-title":"Front Microbiol"},{"key":"pone.0227876.ref045","first-page":"4419","article-title":"Homology modeling of target proteins and identification novel antifungal compounds against Candida tropicalis through structure based virtual screening","author":"H Ravinarayanan","year":"2015","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"pone.0227876.ref046","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2217\/fmb-2017-0065","article-title":"A new small-molecule KRE2 inhibitor against invasive Candida parapsilosis infection","volume":"12","author":"TP Salci","year":"2017","journal-title":"Future Microbiol"},{"issue":"9","key":"pone.0227876.ref047","doi-asserted-by":"crossref","first-page":"e00165","DOI":"10.1128\/AAC.00165-17","article-title":"Targeting the Homoserine Dehydrogenase of Paracoccidioides Species for Treatment of Systemic Fungal Infections","volume":"61","author":"MC Bagatin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0227876.ref048","doi-asserted-by":"crossref","first-page":"36403","DOI":"10.1038\/srep36403","article-title":"Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei","volume":"6","author":"B Das","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0227876.ref049","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/0255-0857.148404","article-title":"Novel synthetic anti-fungal tripeptide effective against Candida krusei","volume":"33","author":"K Gill","year":"2015","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"pone.0227876.ref050","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"MA Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"Suppl 2","key":"pone.0227876.ref051","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact","volume":"58","author":"M Sanguinetti","year":"2015","journal-title":"Mycoses"},{"issue":"6","key":"pone.0227876.ref052","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1439-0507.2009.01747.x","article-title":"In vitro synergistic effects of metergoline and antifungal agents against Candida krusei","volume":"53","author":"K Kang","year":"2010","journal-title":"Mycoses"},{"issue":"5","key":"pone.0227876.ref053","doi-asserted-by":"crossref","first-page":"e0126393","DOI":"10.1371\/journal.pone.0126393","article-title":"Synergistic antifungal activity of berberine derivative B-7b and fluconazole","volume":"10","author":"LP Li","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0227876.ref054","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/13880209.2016.1242631","article-title":"In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates","volume":"55","author":"RC Moraes","year":"2016","journal-title":"Pharm Biol"},{"issue":"8","key":"pone.0227876.ref055","first-page":"859","article-title":"In vitro combination therapy with isavuconazole against Candida spp","volume":"55","author":"A Katragkou","year":"2017","journal-title":"Med Mycol"},{"key":"pone.0227876.ref056","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.micpath.2017.04.021","article-title":"Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates","volume":"107","author":"A Sharifzadeh","year":"2017","journal-title":"Microb Pathog"},{"issue":"18","key":"pone.0227876.ref057","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1007\/s00253-017-8442-y","article-title":"Antifungal mechanism of the combination of Cinnamomum verum and Pelargonium graveolens essential oils with fluconazole against pathogenic Candida strains","volume":"101","author":"R Essid","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"pone.0227876.ref058","first-page":"331","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"WR Greco","year":"1995","journal-title":"Pharmacol Rev"},{"issue":"8","key":"pone.0227876.ref059","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"RL White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0227876.ref060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/49.2.345","article-title":"Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species","volume":"49","author":"RE Lewis","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pone.0227876.ref061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"FC Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"pone.0227876.ref062","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13693780410001731547","article-title":"Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models","volume":"43","author":"J Meletiadis","year":"2005","journal-title":"Med Mycol"},{"issue":"6","key":"pone.0227876.ref063","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/IAI.00044-11","article-title":"The Interaction between Candida krusei and Murine Macrophages Results in Multiple Outcomes, Including Intracellular Survival and Escape from Killing","volume":"79","author":"R Garc\u00eda-Rodas","year":"2011","journal-title":"Infect Immun"},{"issue":"2","key":"pone.0227876.ref064","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000321157","article-title":"Organ-specific innate immune responses in a mouse model of invasive candidiasis","volume":"3","author":"MS Lionakis","year":"2011","journal-title":"J Innate Immun"},{"issue":"9","key":"pone.0227876.ref065","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/AAC.41.9.1937","article-title":"Treatment of murine Candida krusei or Candida glabrata infection with L-743,872","volume":"41","author":"JR Graybill","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0227876.ref066","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/dkn431","article-title":"Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei","volume":"63","author":"J Majithiya","year":"2009","journal-title":"J Antimicrob Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T13:46:15Z","timestamp":1579009575000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227876"}},"subtitle":[],"editor":[{"given":"Joy","family":"Sturtevant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227876","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]}}}